Hope For Substance Abuse, Mental Disorder Recovery 

Translate to Spanish or other 102 languages!

The UTRGV Institute for Neuroscience, ION, conducts clinical and scientific research to help create better treatments and improve people’s life. Some of these studies include Addiction and Mood Disorders, Bipolar Disorder and Alcohol Use Disorder, Depression and Alcohol Use Disorders, Spinal Cord Injury, Alzheimer’s Disease and Neuromodulation Research. (UTRGV Photo) Dr. Ihsan Salloum is a board-certified psychiatrist who has conducted treatment studies for both mental and substance disorders for many years and knows that these are brain diseases that can be effectively treated. (UTRGV Photo by David Pike) 
The UTRGV Institute for Neuroscience, ION, conducts clinical and scientific research to help create better treatments and improve people’s life. Some of these studies include Addiction and Mood Disorders, Bipolar Disorder and Alcohol Use Disorder, Depression and Alcohol Use Disorders, Spinal Cord Injury, Alzheimer’s Disease and Neuromodulation Research. (UTRGV Photo) Dr. Ihsan Salloum is a board-certified psychiatrist who has conducted treatment studies for both mental and substance disorders for many years and knows that these are brain diseases that can be effectively treated. (UTRGV Photo by David Pike) 

Texas Border Business

- Advertisement -

By Saira Cabrera  

EDINBURG, Texas – Dr. Ihsan Salloum – the Sujata G. Krishnan Endowed Chair, Joe R. and Teresa Lozano Long distinguished professor in Neuroscience, founding chair of the UTRGV Department of Neuroscience, and director of the Institute for Neuroscience (ION) at the UTRGV School of Medicine – said both mental and substance disorders are brain diseases that can be treated medically.  

“Substance abuse and mental health are both brain diseases,” Salloum said. “All the scientific information that has been gathered over the past 30, 40 years indicates that substance use is a brain disorder, as well as a mental disorder. But things are complicated because there is an interaction between our constitution and vulnerability and the environment in which we live and grow up. The context is crucial.”  

- Advertisement -

SUBSTANCE ABUSE AND MENTAL HEALTH 

Salloum said 50 million people in the United States alone have these two disorders. But better treatments can be developed for specific needs through investigative studies, such as the ones conducted at UTRGV’s ION. 

“The goal of these studies is to develop a specific treatment for people suffering from substance use, or substance use combined with mental illness,” he said. 

Information about the causes of the disorders and the available treatments is of utmost importance, he said, because it leaves no place for stigma. 

- Advertisement -

“Just like any other problem we can have in our bodies, people respond to treatment,” he said. “Like other chronic diseases that people recover from, in the same way, people with mental and substance disorders can be treated and can overcome this problem.” 

Just as any other part of the body that can get sick, so can the brain, and addiction and mental disorders are part of that.  

“The good news is that if we have some genetic vulnerability, it doesn’t mean that is our destiny. Some people have a propensity maybe to develop cancer because they got exposed to certain environmental factors,” Salloum said. “In the same way, people have a vulnerability, a genetic vulnerability, to develop an addiction if they get exposed to the addictive substance.”  

By knowing a person’s vulnerability, those disorders potentially can be avoided.  

ION – TRANSFORMING BRAIN HEALTH  

“We know that people with addiction and mental disorders do respond to treatment, and they do recover and are able to overcome this problem,” Salloum said. “Treatment is very beneficial.” 

To find treatment and medication that can assist in helping battle these diseases, UTRGV’s ION conducts clinical and scientific research to help create better-responding treatments. Some of the studies include:

  • Addiction and Mood Disorders.  
  • Bipolar Disorder and Alcohol Use Disorder.  
  • Depression and Alcohol Use Disorders. 
  • Neuromodulation Research.  

The investigations are still in the study stages, Salloum said, but believes there is “light at the end of the tunnel.” To avoid setbacks, he said, an easy preventative step is to practice self-care.  

“I think it’s essential to educate oneself about what we have. Self-care is one of the most important things for people to help themselves recover from substance use,” he said. 

SUBSTANCE ABUSE RESOURCES  

Salloum recommends established groups that can help, like Alcoholics Anonymous, part of a support network of helpful anonymous groups.  

He also believes it is imperative to remember that the path to recovery is a process. 

“If you relapse, you can still pick up where you left off,” he said. “We need to give people a chance and space and understand what they’re going through.”  

To help avoid relapse and be successful in achieving recovery, Salloum recommends:

  • Educating oneself about health conditions and what may trigger others. 
  • Joining groups such as Alcoholics Anonymous, that may help in providing support networks. 
  • Avoiding certain people, places, things and stressors that can trigger negative behaviors. 
  • Practicing self-care. 
  • Seeking protection from what causes or caused the addiction. 

Currently, at the ION, several studies and treatments are underway that could help with substance dependency and mental disorders.  

“Reach out to our offices and ask for more information,” he said. “We not only can help our community, but also help inform the nation about findings for specific studies.”  

To find resources regarding substance dependency and mental disorders provided at the ION and to participate in research studies, visit UTHealthRGV.org.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Cancer Care Services with Radiation Oncologist, Dr. Jason Shumadine Wolff

DHR Health, one of the largest physician-owned hospitals in the United States and a proud healthcare provider for the Rio Grande Valley since 1997, is delighted to welcome Dr. Jason Shumadine Wolff, to its growing network of specialty care physicians.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.

STHS Edinburg Teams Up with Reserva Coffee Roasters for Premium Patient Experience

With the grand opening of Reserva Coffee Roasters’ newest café, the warmth and comfort of home are now just a brew away at South Texas Health System Edinburg (STHS) and STHS Children’s, helping create the perfect setting for connection, conversation and community for hospital visitors, staff and physicians.

McAllen Mayor Leads Public Push for Early Lung Cancer Detection

McAllen Mayor Javier Villalobos hosted a televised discussion on lung cancer awareness with pulmonologist Juan P. Rey Mendoza and retired McAllen Police Lieutenant Joel Morales to encourage Rio Grande Valley residents to seek screening and recognize the risks of delayed diagnosis.
- Advertisement -